SlideShare a Scribd company logo
1 of 41
In the name of God
1
premature ovarian
failure(POF)?
Supervisor : Dr . Bahmanpour
Presenting by : Eisa . Moradiyan
2Department of anatomical sciences
What is the premature ovarian
failure(POF)?
(POF)
↓
characterized by
↓
premature depletion of ovarian follicles before the age
of 40 years, representing one major cause of female
infertility
3
Anatomy
4
(POF)
• (FSH) > 20 to 40 mIU/mL < 40 years
• 1% to 3% of women experience POF
• primary amenorrhea
• secondary amenorrhea
• POF may become pregnant spontaneously albeit
the likelihood is low
5
(POF)
• The incidence is lower in younger women.
• variety of mechanisms and highly heterogeneous
6
7
• I Genetic aberrations (X chromosome or
autosome)
• II Autoimmune ovarian damage
• III Environmental factors
• IV Iatrogenic (surgical, radio or chemotherapy)
• V Metabolic changes (galactosaemia …)
• VI Defect in structure/effects of gonadotrophins
• VII Idiopathic
Cause of POF
• Genetic aberrations (in some Cases):
45,X or Turner syndrome
Fragile X syndrome
Deletions of the short or long arm of the X chromosome
Fetuses Trisomy 13 and 18 ovarian dysgenesis
Numerous autosomal genes mutation(ovarian
development) 9
Cause of POF
(APS type 1 and 2)
Perrault syndrome(POF and neurosensory deafness)
Ataxia telangiectasia(ATM gene)
Type I blepharophimosis, ptosis, epicanthus inversus
syndrome can present with POF(FOXL2 mutations)
10
Cause of POF
 Perturbations of somatic genes (FSHR, LHR)
 It is estimated that the cause of 90% of the primary POF
cases still remains unknown
11
Turner syndrome
• abnormalities is 45,X
• affects 1 in 2500 female
• spontaneous abortion (75%)
• short stature
• cardiovascular anomalies (coarctation of the aorta
and aortic valvular abnormalities)
• webbed neck
• lymphedema
• Ovarian dysgenesis
12
Turner syndrome
13
Deletions of the short or long arm of
the X chromosome
• variable phenotype
• Proximal deletions of Xq21(primary amenorrhea)
• Xp another phenotype
• critical region : at Xq13.3-Xq27
14
Deletions of the short or long arm of
the X chromosome
15
Fragile X syndrome
• located on chromosome Xq27.3
• Premutation, <200 CGG repeats
• Gene FMRI
• between 3% and 12% depending on the family
history.
• approximately 20% of the fragile X carriers
develop POF.
16
Fragile X syndrome
17
Trisomy 13 and 18
18
Mutation Numerous autosomal
genes(ovarian development)
19
BMP-15 and GDF-9.31
20
Autoimmune polyendocrine
syndrome (APS) type 1 and 2
• (APS) type 1: AIRE Genes
• adrenal insufficiency
• hypoparathyroidism
• Hypothyroidism
• type 1 diabetes mellitus
• ovarian failure
21
Perrault syndrome
• Both males and females
• Sensorineural hearing loss
• Ovarian dysgenesis
• Mutation TWNK, CLPP, HSD17B4, and LARS2
genes
• External genitalia are normal
22
Perrault syndrome
23
Ataxia telangiectasia
• Defective DNA repair mechanisms
• ATM gene
24
Blepharophimosis–ptosis–epicanthus
inversus
syndrome(BPES)
• Mutation FOXL2 genes (eyelids and ovaries)
• Eyelid malformations
• POF
25
Blepharophimosis–ptosis–epicanthus
inversus
syndrome (BPES)
26
Iatrogenic
• Chemotherapy
• Irradiation
• Infections such as mumps oophoritis
27
Chemotherapy
28
Chemotherapy
Treatment by CYC
Ovarian
atrophy
Reduce
number of
follicles
growing
Increased
ovarian
fibrosis
Reduce
number of
primordial
follicles
29Xiu- yinchenal et al, 2016
Irradiation
• Patient’s age
• The x-ray dose
• Younger women (less likely to have POF)
• Gonadotropins levels rise after irradiation
.
30
Risk Factors
• Age : The risk of ovarian failure rises sharply
between age 35 and age 40
• Family history : Having a family history of
premature ovarian failure increases your risk of
developing this disorder.
31
Symptoms
32
Irregular or
skipped periods
Hot flashes
Decreased
sexual desire
Vaginal
dryness
Night sweats
33
POF
osteoporosis
osteoarthritis
cardiovascular
disease
neurodegenerative
diseases
Diagnostic workup of POF
• Follicle-stimulating hormone (FSH) test.
• Estradiol test.
• Prolactin test
• Karyotype
• FMR1 gene testing.
34
History
1. Last spontaneous menstrual cycle
2. Prior pelvic surgeries, irradiation, or
chemotherapy
3. Symptoms of adrenal insufficiency:
Skin hyperpigmentation
Salt craving
Abdominal pain
5. mental retardation,autoimmune disorders
6. Symptoms of estrogen deprivation
35
Managment
• Hormone replacement therapy (HRT)Estrogens
Estrogens→ orally or transdermally
Progestins → 10-14 days each month, to prevent
endometrial hyperplasia
Androgens → methyl testosterone → 1.25-2.5
mg/d
36
Restoration fertility
• Steroids ≠ autoimmune POF→ osteonecrosis
• Gonadotropin therapy → risk of exacerbating
autoimmune POF
• ART
Oocyte donation
Embryo adoption
 Surrogacy
 Ovarian cryopreservation
37
Life style modification
• Diet
– Elemental Calcium : 1200-1500 mg day.
– Adequate intake of vitamin D.
• Activity
– exercises for 30 at least 3 days per week improve
muscle strength and maintain bone mass
38
• 1. Bilgin EM, Kovanci E. Genetics of premature ovarian failure. Current Opinion in
Obstetrics and Gynecology. 2015;27(3):167-74.
• 2. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is
mutated in patients with premature ovarian failure. Am J Hum Genet. 2008;82(6):1342-8.
• 3. Chapman C, Cree L, Shelling AN. The genetics of premature ovarian failure: current
perspectives. International journal of women's health. 2015;7:799.
• 4. Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, et al.
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced
premature ovarian failure in cancer women: systematic review and meta-analysis of
randomized trials. Cancer treatment reviews. 2014;40(5):675-83.
• 5. Jankowska K. Premature ovarian failure. Przegla̜ d Menopauzalny= Menopause Review.
2017;16(2):51.
• 6. Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment.
Obstet Gynecol Clin North Am. 2015;42(1):153-61.
• 7. Lai D, Wang F ,Yao X, Zhang Q, Wu X, Xiang C. Human endometrial mesenchymal
stem cells restore ovarian function through improving the renewal of germline stem cells in a
mouse model of premature ovarian failure. Journal of translational medicine. 2015;13(1):155.
• 8. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian
failure. Journal of molecular endocrinology. 2010;45(5):257-79.
• 9. Rossetti R, Ferrari I, Bonomi M, Persani L. Genetics of primary ovarian insufficiency.
Clinical genetics. 2017 ;91)2:)183-98.
• 10. Yang JJ, Cho LY, Lim YJ, Ko K-P, Lee K-S, Kim H, et al. Estrogen receptor-1 genetic
polymorphisms for the risk of premature ovarian failure and early menopause. Journal of
Women's Health. 2010;19(2):297-304.
39
40
Life is short.
cut out negativity,
forget gossip,
forgive who hurt you .
Spend your days with peopele
who are always there
41

More Related Content

What's hot

Puberty menorrhagia dr. kawita bapat
Puberty menorrhagia dr. kawita bapatPuberty menorrhagia dr. kawita bapat
Puberty menorrhagia dr. kawita bapatKawita Bapat
 
Primary ovarian insufficiency
Primary ovarian insufficiencyPrimary ovarian insufficiency
Primary ovarian insufficiencyNarmeen Hassan
 
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementRecent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementAtef Darwish
 
CLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANI
CLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANICLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANI
CLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...Lifecare Centre
 
Diagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertilityDiagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertilitySanjay Makwana
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilBharati Dhorepatil
 
Adjuvants in por (1)
Adjuvants in por (1)Adjuvants in por (1)
Adjuvants in por (1)rupalibassi
 
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Uterine fibroids ( Myomas ) and infertility
Uterine fibroids  ( Myomas ) and infertilityUterine fibroids  ( Myomas ) and infertility
Uterine fibroids ( Myomas ) and infertilityMarwan Alhalabi
 
Clomiphene Citrate Stimulation Protocol for Non IVF Cycle
Clomiphene Citrate Stimulation Protocol for Non IVF CycleClomiphene Citrate Stimulation Protocol for Non IVF Cycle
Clomiphene Citrate Stimulation Protocol for Non IVF CycleDr.Laxmi Agrawal Shrikhande
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation inductionnermine amin
 

What's hot (20)

Puberty menorrhagia dr. kawita bapat
Puberty menorrhagia dr. kawita bapatPuberty menorrhagia dr. kawita bapat
Puberty menorrhagia dr. kawita bapat
 
Primary ovarian insufficiency
Primary ovarian insufficiencyPrimary ovarian insufficiency
Primary ovarian insufficiency
 
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assementRecent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
Recent 2018 ESHRE & ASRM evidence based guidelines for PCOS assement
 
Menopause
MenopauseMenopause
Menopause
 
CLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANI
CLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANICLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANI
CLINICAL DIAGNOSIS AND MANAGEMENT OF AMENORRHOEA BY DR SHASHWAT JANI
 
GnRH antagonists
GnRH antagonistsGnRH antagonists
GnRH antagonists
 
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal  Dr. Jyoti Bh...
Ovulation Induction in I.U.I. Dr. Sharda Jain Dr. Jyoti Agarwal Dr. Jyoti Bh...
 
Diagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertilityDiagnosis and classification of tubal factor infertility
Diagnosis and classification of tubal factor infertility
 
Treatment of decreased ovarian reserve
Treatment of decreased ovarian reserveTreatment of decreased ovarian reserve
Treatment of decreased ovarian reserve
 
Complete Guide To Infertility
Complete Guide To InfertilityComplete Guide To Infertility
Complete Guide To Infertility
 
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati DhorepatilPCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
PCOS - Ovulation Induction 1 - Dr Bharati Dhorepatil
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
 
Induction of ovulation
Induction of ovulationInduction of ovulation
Induction of ovulation
 
Adjuvants in por (1)
Adjuvants in por (1)Adjuvants in por (1)
Adjuvants in por (1)
 
Dhea jdr
Dhea jdrDhea jdr
Dhea jdr
 
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANIMANAGEMENT OF POOR RESPONDERS  IN IVF BY DR SHASHWAT JANI
MANAGEMENT OF POOR RESPONDERS IN IVF BY DR SHASHWAT JANI
 
Uterine fibroids ( Myomas ) and infertility
Uterine fibroids  ( Myomas ) and infertilityUterine fibroids  ( Myomas ) and infertility
Uterine fibroids ( Myomas ) and infertility
 
Clomiphene Citrate Stimulation Protocol for Non IVF Cycle
Clomiphene Citrate Stimulation Protocol for Non IVF CycleClomiphene Citrate Stimulation Protocol for Non IVF Cycle
Clomiphene Citrate Stimulation Protocol for Non IVF Cycle
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
 
Luteal Phase Support
 Luteal Phase Support Luteal Phase Support
Luteal Phase Support
 

Similar to Premature ovarian failure . e . m

Evaluating a couple with infertility
Evaluating a couple with infertilityEvaluating a couple with infertility
Evaluating a couple with infertilityArthurMpower
 
PREMATURE OVARIAN INSUFFICIENCY (POI)
PREMATURE OVARIAN INSUFFICIENCY(POI)PREMATURE OVARIAN INSUFFICIENCY(POI)
PREMATURE OVARIAN INSUFFICIENCY (POI)Dr. Sunita Chandra
 
Endo Reproduction
Endo ReproductionEndo Reproduction
Endo ReproductionMiami Dade
 
Anormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.com
Anormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.comAnormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.com
Anormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Male infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha JainMale infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha JainDr. Preksha Jain
 
male infertility causes, management .pptx
male infertility causes, management .pptxmale infertility causes, management .pptx
male infertility causes, management .pptxzamurdabbas
 
Approach to infertility by dr.bagasi
Approach to infertility by dr.bagasiApproach to infertility by dr.bagasi
Approach to infertility by dr.bagasiAbdulaziz Bagasi
 
Male infertility (2)
Male infertility (2)Male infertility (2)
Male infertility (2)obgymgmcri
 
Infertility Overview, Approach and Evaluation
Infertility Overview, Approach and EvaluationInfertility Overview, Approach and Evaluation
Infertility Overview, Approach and Evaluationedenfertilitycenters
 
Woman Health 2023 PPT.pdf
Woman Health 2023 PPT.pdfWoman Health 2023 PPT.pdf
Woman Health 2023 PPT.pdfWafa sheikh
 
Male Infertility- How Gynaecologists can manage?
Male Infertility- How Gynaecologists can manage?Male Infertility- How Gynaecologists can manage?
Male Infertility- How Gynaecologists can manage?Sujoy Dasgupta
 
Infertility ppt
Infertility pptInfertility ppt
Infertility pptKaveriS14
 
Evaluation of male infertility
Evaluation of male infertility Evaluation of male infertility
Evaluation of male infertility SomendraBansal
 

Similar to Premature ovarian failure . e . m (20)

Evaluating a couple with infertility
Evaluating a couple with infertilityEvaluating a couple with infertility
Evaluating a couple with infertility
 
Subfertility
SubfertilitySubfertility
Subfertility
 
Failing ovary
Failing ovaryFailing ovary
Failing ovary
 
PREMATURE OVARIAN INSUFFICIENCY (POI)
PREMATURE OVARIAN INSUFFICIENCY(POI)PREMATURE OVARIAN INSUFFICIENCY(POI)
PREMATURE OVARIAN INSUFFICIENCY (POI)
 
Endo Reproduction
Endo ReproductionEndo Reproduction
Endo Reproduction
 
Workshop d1
Workshop d1Workshop d1
Workshop d1
 
Anormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.com
Anormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.comAnormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.com
Anormal Seksüel Gelişim - İnterseks - www.jinekolojivegebelik.com
 
Male infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha JainMale infertility by Dr. Preksha Jain
Male infertility by Dr. Preksha Jain
 
male infertility causes, management .pptx
male infertility causes, management .pptxmale infertility causes, management .pptx
male infertility causes, management .pptx
 
Approach to infertility by dr.bagasi
Approach to infertility by dr.bagasiApproach to infertility by dr.bagasi
Approach to infertility by dr.bagasi
 
Amenore - www.jinekolojivegebelik.com
Amenore - www.jinekolojivegebelik.comAmenore - www.jinekolojivegebelik.com
Amenore - www.jinekolojivegebelik.com
 
Male infertility (2)
Male infertility (2)Male infertility (2)
Male infertility (2)
 
Infertility Overview, Approach and Evaluation
Infertility Overview, Approach and EvaluationInfertility Overview, Approach and Evaluation
Infertility Overview, Approach and Evaluation
 
Ambiguous Genitalia
Ambiguous GenitaliaAmbiguous Genitalia
Ambiguous Genitalia
 
Woman Health 2023 PPT.pdf
Woman Health 2023 PPT.pdfWoman Health 2023 PPT.pdf
Woman Health 2023 PPT.pdf
 
Infertility.pptx
Infertility.pptxInfertility.pptx
Infertility.pptx
 
Male Infertility- How Gynaecologists can manage?
Male Infertility- How Gynaecologists can manage?Male Infertility- How Gynaecologists can manage?
Male Infertility- How Gynaecologists can manage?
 
Amenorrhea NISHTAR
Amenorrhea NISHTARAmenorrhea NISHTAR
Amenorrhea NISHTAR
 
Infertility ppt
Infertility pptInfertility ppt
Infertility ppt
 
Evaluation of male infertility
Evaluation of male infertility Evaluation of male infertility
Evaluation of male infertility
 

Recently uploaded

CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupJonathanParaisoCruz
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersSabitha Banu
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...M56BOOKSTORE PRODUCT/SERVICE
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 

Recently uploaded (20)

CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
MARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized GroupMARGINALIZATION (Different learners in Marginalized Group
MARGINALIZATION (Different learners in Marginalized Group
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
DATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginnersDATA STRUCTURE AND ALGORITHM for beginners
DATA STRUCTURE AND ALGORITHM for beginners
 
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
KSHARA STURA .pptx---KSHARA KARMA THERAPY (CAUSTIC THERAPY)————IMP.OF KSHARA ...
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 

Premature ovarian failure . e . m

  • 1. In the name of God 1
  • 2. premature ovarian failure(POF)? Supervisor : Dr . Bahmanpour Presenting by : Eisa . Moradiyan 2Department of anatomical sciences
  • 3. What is the premature ovarian failure(POF)? (POF) ↓ characterized by ↓ premature depletion of ovarian follicles before the age of 40 years, representing one major cause of female infertility 3
  • 5. (POF) • (FSH) > 20 to 40 mIU/mL < 40 years • 1% to 3% of women experience POF • primary amenorrhea • secondary amenorrhea • POF may become pregnant spontaneously albeit the likelihood is low 5
  • 6. (POF) • The incidence is lower in younger women. • variety of mechanisms and highly heterogeneous 6
  • 7. 7
  • 8. • I Genetic aberrations (X chromosome or autosome) • II Autoimmune ovarian damage • III Environmental factors • IV Iatrogenic (surgical, radio or chemotherapy) • V Metabolic changes (galactosaemia …) • VI Defect in structure/effects of gonadotrophins • VII Idiopathic
  • 9. Cause of POF • Genetic aberrations (in some Cases): 45,X or Turner syndrome Fragile X syndrome Deletions of the short or long arm of the X chromosome Fetuses Trisomy 13 and 18 ovarian dysgenesis Numerous autosomal genes mutation(ovarian development) 9
  • 10. Cause of POF (APS type 1 and 2) Perrault syndrome(POF and neurosensory deafness) Ataxia telangiectasia(ATM gene) Type I blepharophimosis, ptosis, epicanthus inversus syndrome can present with POF(FOXL2 mutations) 10
  • 11. Cause of POF  Perturbations of somatic genes (FSHR, LHR)  It is estimated that the cause of 90% of the primary POF cases still remains unknown 11
  • 12. Turner syndrome • abnormalities is 45,X • affects 1 in 2500 female • spontaneous abortion (75%) • short stature • cardiovascular anomalies (coarctation of the aorta and aortic valvular abnormalities) • webbed neck • lymphedema • Ovarian dysgenesis 12
  • 14. Deletions of the short or long arm of the X chromosome • variable phenotype • Proximal deletions of Xq21(primary amenorrhea) • Xp another phenotype • critical region : at Xq13.3-Xq27 14
  • 15. Deletions of the short or long arm of the X chromosome 15
  • 16. Fragile X syndrome • located on chromosome Xq27.3 • Premutation, <200 CGG repeats • Gene FMRI • between 3% and 12% depending on the family history. • approximately 20% of the fragile X carriers develop POF. 16
  • 18. Trisomy 13 and 18 18
  • 19. Mutation Numerous autosomal genes(ovarian development) 19 BMP-15 and GDF-9.31
  • 20. 20
  • 21. Autoimmune polyendocrine syndrome (APS) type 1 and 2 • (APS) type 1: AIRE Genes • adrenal insufficiency • hypoparathyroidism • Hypothyroidism • type 1 diabetes mellitus • ovarian failure 21
  • 22. Perrault syndrome • Both males and females • Sensorineural hearing loss • Ovarian dysgenesis • Mutation TWNK, CLPP, HSD17B4, and LARS2 genes • External genitalia are normal 22
  • 24. Ataxia telangiectasia • Defective DNA repair mechanisms • ATM gene 24
  • 25. Blepharophimosis–ptosis–epicanthus inversus syndrome(BPES) • Mutation FOXL2 genes (eyelids and ovaries) • Eyelid malformations • POF 25
  • 27. Iatrogenic • Chemotherapy • Irradiation • Infections such as mumps oophoritis 27
  • 29. Chemotherapy Treatment by CYC Ovarian atrophy Reduce number of follicles growing Increased ovarian fibrosis Reduce number of primordial follicles 29Xiu- yinchenal et al, 2016
  • 30. Irradiation • Patient’s age • The x-ray dose • Younger women (less likely to have POF) • Gonadotropins levels rise after irradiation . 30
  • 31. Risk Factors • Age : The risk of ovarian failure rises sharply between age 35 and age 40 • Family history : Having a family history of premature ovarian failure increases your risk of developing this disorder. 31
  • 32. Symptoms 32 Irregular or skipped periods Hot flashes Decreased sexual desire Vaginal dryness Night sweats
  • 34. Diagnostic workup of POF • Follicle-stimulating hormone (FSH) test. • Estradiol test. • Prolactin test • Karyotype • FMR1 gene testing. 34
  • 35. History 1. Last spontaneous menstrual cycle 2. Prior pelvic surgeries, irradiation, or chemotherapy 3. Symptoms of adrenal insufficiency: Skin hyperpigmentation Salt craving Abdominal pain 5. mental retardation,autoimmune disorders 6. Symptoms of estrogen deprivation 35
  • 36. Managment • Hormone replacement therapy (HRT)Estrogens Estrogens→ orally or transdermally Progestins → 10-14 days each month, to prevent endometrial hyperplasia Androgens → methyl testosterone → 1.25-2.5 mg/d 36
  • 37. Restoration fertility • Steroids ≠ autoimmune POF→ osteonecrosis • Gonadotropin therapy → risk of exacerbating autoimmune POF • ART Oocyte donation Embryo adoption  Surrogacy  Ovarian cryopreservation 37
  • 38. Life style modification • Diet – Elemental Calcium : 1200-1500 mg day. – Adequate intake of vitamin D. • Activity – exercises for 30 at least 3 days per week improve muscle strength and maintain bone mass 38
  • 39. • 1. Bilgin EM, Kovanci E. Genetics of premature ovarian failure. Current Opinion in Obstetrics and Gynecology. 2015;27(3):167-74. • 2. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet. 2008;82(6):1342-8. • 3. Chapman C, Cree L, Shelling AN. The genetics of premature ovarian failure: current perspectives. International journal of women's health. 2015;7:799. • 4. Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer treatment reviews. 2014;40(5):675-83. • 5. Jankowska K. Premature ovarian failure. Przegla̜ d Menopauzalny= Menopause Review. 2017;16(2):51. • 6. Kovanci E, Schutt AK. Premature ovarian failure: clinical presentation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):153-61. • 7. Lai D, Wang F ,Yao X, Zhang Q, Wu X, Xiang C. Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure. Journal of translational medicine. 2015;13(1):155. • 8. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. Journal of molecular endocrinology. 2010;45(5):257-79. • 9. Rossetti R, Ferrari I, Bonomi M, Persani L. Genetics of primary ovarian insufficiency. Clinical genetics. 2017 ;91)2:)183-98. • 10. Yang JJ, Cho LY, Lim YJ, Ko K-P, Lee K-S, Kim H, et al. Estrogen receptor-1 genetic polymorphisms for the risk of premature ovarian failure and early menopause. Journal of Women's Health. 2010;19(2):297-304. 39
  • 40. 40
  • 41. Life is short. cut out negativity, forget gossip, forgive who hurt you . Spend your days with peopele who are always there 41

Editor's Notes

  1. Obstet Gynecol Clin N Am 42 (2015)
  2. Obstet Gynecol Clin N Am 42 (2015)
  3. Obstet Gynecol Clin N Am 42 (2015)
  4. Obstet Gynecol Clin N Am 42 (2015)
  5. Obstet Gynecol Clin N Am 42 (2015)
  6. Obstet Gynecol Clin N Am 42 (2015)
  7. UPTODate It is caused by expansion of a repetition of the cytosine–guanine–guanine trinucleotide segment (CGG)
  8. Obstet Gynecol Clin N Am 42 (2015)
  9. Obstet Gynecol Clin N Am 42 (2015)
  10. Obstet Gynecol Clin N Am 42 (2015)
  11. Obstet Gynecol Clin N Am 42 (2015)
  12. W
  13. W
  14. Obstet Gynecol Clin N Am 42 (2015) 153–161 Premature Ovarian Failure Clinical Presentation and Treatment